Share URL
Embed chart view
StockViz
Clarivate Plc
NYSE:CLVT
Sector
Location
Market Cap
USD 3.02 B
Share Price
USD 4.50
Avg Daily Volume
5,038,209
Change (1 day)
2.27%
Change (1 year)
-30.02%
Change (YTD)
-11.42%
Clarivate Plc Enterprise Value to EBITDA (EV/EBITDA) on August 22, 2025: 10.65
Clarivate Plc Enterprise Value to EBITDA (EV/EBITDA) is 10.65 on August 22, 2025, a -122.65% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
-
Clarivate Plc 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 17.34 on August 22, 2025, which is 62.81% above the current Enterprise Value to EBITDA (EV/EBITDA).
-
Clarivate Plc 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -48.78 on August 22, 2025, which is -557.97% below the current Enterprise Value to EBITDA (EV/EBITDA).
-
Clarivate Plc average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is -12.41.
Competitors
Eli Lilly and Company
USD 711.68
LLY
+1.86
0.26%
AbbVie Inc.
USD 210.60
ABBV
+1.10
0.53%
Roche Holding AG
USD 340.96
RO.SW
+1.66
0.49%
Novartis AG
USD 127.06
NOVN.SW
-0.12
-0.10%
Novo Nordisk A/S
USD 56.99
NOVO-B.CO
+1.76
3.18%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 132.59
ABT
+0.59
0.45%
Merck & Co., Inc.
USD 87.37
MRK
+1.29
1.50%
Thermo Fisher Scientific Inc.
USD 499.99
TMO
+16.23
3.36%
Amgen Inc.
USD 293.72
AMGN
-2.04
-0.69%
Pfizer Inc.
USD 25.88
PFE
+0.14
0.54%
Gilead Sciences, Inc.
USD 114.77
GILD
-1.37
-1.18%
Sanofi
USD 102.38
SAN.PA
+0.86
0.84%
Vertex Pharmaceuticals Incorporated
USD 395.12
VRTX
-2.34
-0.59%
Bristol-Myers Squibb Company
USD 47.92
BMY
-0.51
-1.05%
Key Data
| Date | Enterprise Value to EBITDA (EV/EBITDA) | Free Cash Flow Yield | Dividend Yield | Market Capitalization |
|---|
Competitors
Eli Lilly and Company
USD 711.68
LLY
+1.86
0.26%
AbbVie Inc.
USD 210.60
ABBV
+1.10
0.53%
Roche Holding AG
USD 340.96
RO.SW
+1.66
0.49%
Novartis AG
USD 127.06
NOVN.SW
-0.12
-0.10%
Novo Nordisk A/S
USD 56.99
NOVO-B.CO
+1.76
3.18%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 132.59
ABT
+0.59
0.45%
Merck & Co., Inc.
USD 87.37
MRK
+1.29
1.50%
Thermo Fisher Scientific Inc.
USD 499.99
TMO
+16.23
3.36%
Amgen Inc.
USD 293.72
AMGN
-2.04
-0.69%
Pfizer Inc.
USD 25.88
PFE
+0.14
0.54%
Gilead Sciences, Inc.
USD 114.77
GILD
-1.37
-1.18%
Sanofi
USD 102.38
SAN.PA
+0.86
0.84%
Vertex Pharmaceuticals Incorporated
USD 395.12
VRTX
-2.34
-0.59%
Bristol-Myers Squibb Company
USD 47.92
BMY
-0.51
-1.05%